<DOC>
	<DOCNO>NCT02322255</DOCNO>
	<brief_summary>Fibrodysplasia Ossificans Progressiva ( FOP ) rare , severely disable disease characterize painful , recurrent episode soft tissue swell ( flare-up ) result abnormal bone formation muscle , tendon , ligament . Flare-ups begin early life may occur spontaneously soft tissue trauma , vaccination , influenza infection . Recurrent flare-ups progressively restrict movement lock joint lead cumulative loss function disability . This 3-year , non-interventional , two-part , natural history study design gain insight total body HO , FOP disease progression , impact FOP subject ' physical functioning , clinical feature biomarkers may useful diagnosis monitoring disease progression . This natural history study also provide important information inform design subsequent interventional trial .</brief_summary>
	<brief_title>A Natural History Study Fibrodysplasia Ossificans Progressiva ( FOP )</brief_title>
	<detailed_description>This multi-center , natural history , non-interventional , longitudinal study subject classic FOP . A thorough baseline examination perform determine current status disease subject . In Part A , two image modality assess total body HO baseline , optimal method ( low-dose whole body CT scan [ exclude head ] ) employ Part B balance study . Progression assess annual in-clinic visit ( ie , Months 12 , 24 , 36 ) time procedure conduct baseline visit repeat . In addition , site personnel telephone subject midway annual visit ( ie , Months 6 , 18 , 30 ) . During 36-month follow-up period , least one new flare-up ( maximum one per year ) carefully study . An in-clinic visit perform within 14 day follow subject 's identification his/her flare-up . Additional visit Day 42 Day 84 ( initial flare-up clinic visit ) perform . An additional future visit may schedule Day 84 discretion Principal Investigator ( PI ) prolong flare-up . However , subject eligible flare-up may elect participate ongoing Clementia interventional study rather continue natural history study .</detailed_description>
	<mesh_term>Myositis Ossificans</mesh_term>
	<criteria>Subjects clinically diagnose classical FOP document R206H mutation believe carry R206H mutation Participation interventional clinical research study within 4 week prior enrollment</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Natural History Study</keyword>
	<keyword>Non-interventional Study</keyword>
	<keyword>Observational Study</keyword>
	<keyword>Heterotopic ossification</keyword>
	<keyword>Fibrodysplasia Ossificans Progressiva</keyword>
	<keyword>FOP disease progression</keyword>
	<keyword>FOP flare-up progression</keyword>
	<keyword>Clementia</keyword>
	<keyword>Myositosis Ossificans Progressiva</keyword>
	<keyword>Munchmeyer 's Disease</keyword>
	<keyword>FOP</keyword>
	<keyword>Palovarotene</keyword>
</DOC>